Urology Today.net

Site updated at Wednesday, 17 September 2014

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



turner syndrome3 - abiraterone acetate1 - ungal1 - resistant bacteria1 - renal fibrosis1 - critical care1 - low-calorie diet1 - lower urinary tract symptom score1 - overhydration1 - hyperuricemia1 - life after prostate cancer1 - hepatolenticular degeneration1 - bps1 - disease-related anemia1 - higher blood pressure1 - intravenous pyelography5 - kidney cancer10 - intracytoplasmic sperm injection1 - british journal of urology international1 - canadian institute of health information1 - bladder injury1 - prostate cancer risk1 - testicular cancer1 - jama1 - amgen1 - aus1 - radiographic imaging1 - dstyk1 - pten1 - prostate tissue1 -